Psychedelitech Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Psychedelitech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Psychedelitech Inc Today - Breaking & Trending Today

Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc. PsyTech Inc, including the psychiatric therapeutic SaaS platform Tovana Solutions and psychiatric clinical network Tovana Clinics, to become wholly owned subsidiary of the emerging life sciences company

Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc. PsyTech Inc, including the psychiatric therapeutic SaaS platform Tovana Solutions and psychiatric clinical network Tovana Clinics, to become wholly owned subsidiary of the emerging life sciences company
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United States , Nick Opich Fallon Carter , Hayim Raclaw , Matthew Cossel , Allison Soss , Daniel Carcillo , Mcdonald Hopkins , Psytech Inc , Wesana Solutions , Tovana Solutions , Dorsey Whitney , While The Company , Strategic Communications , Founder Of Wesana Health , Garfinkle Biderman , Wesana Health , University Of South Carolina , Company Listing Statement , Wesana Health Holdings Inc , Cassels Brock Blackwell , Psychedelitech Inc , Brainstorm Lab , Wesana Health Holdings , Tovana Solutions , Tovana Clinic , Psytech Connect ,

Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

[December 28, 2020]
Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value
MIAMI, Dec. 28, 2020 (GLOBE NEWSWIRE) Ehave, Inc. (OTC Pink: EHVVF) (the âCompanyâ), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have been prescribed Ketamine infusions, announced today the Company s Board of directors has elected to sell 100% of its Mycotopia Therapies subsidiary to 20/20 Global Inc. (OTC Pink: TWGL) for $350,000 while simultaneously acquiring approximately 75.77% of 20/20 Globalâs outstanding shares from 20/20 Globalâs management.
20/20 Global currently trades on the OTC under the symbol TWGL and is a reporting issuer with the US Securities and Exchange Commission. The transaction is expected to close January 4, 2021. Ehave Chairman and CEO Ben Kaplan will be named as Chairman and CEO of 20/20 Global, with the current 20/20 Global board stepping down upon completio ....

United States , Mark Croskery , Gabe Rodriguez , Ben Kaplan , Global Inc , Electronic Health Records Ehrs , Risk Factors In Ehave Inc , Croskery Capital , Exchange Commission , Company Board , Additional Ehave Inc , Ehave Inc , Psychedelitech Inc , Announces Repositioning , Mycotopia Therapies , Maximize Shareholder , Central America , Croskery Capital Limited , South America , Ehave Dashboard , Electronic Health Records , Ehave Telemetry Portal , Ehave Infinity Portal , Mycotopia Therapy , Private Securities Litigation Reform Act , Registration Statement ,